Showing results (51-60 of 681) with videos related to
Sort By:
Pageof 69
Expert Review of Hematology|March 22, 2022
Managing patients with myelofibrosis and thrombocytopeniaMusa Yilmaz, Srdan VerstovsekCancer Journal (Sudbury, Mass.)|November 23, 2007
Hypereosinophilic syndrome, chronic eosinophilic leukemia, and mast cell diseaseAnimesh Pardanani, Srdan VerstovsekBlood|July 5, 2017
Clonal evolution and outcomes in myelofibrosis after ruxolitinib discontinuationKate J Newberry, Keyur Patel, Lucia Masarova, et al.Cancer|May 27, 2023
The role of therapy in the outcome of patients with myelofibrosisLucia Masarova, Prithviraj Bose, Naveen Pemmaraju, et al.Expert Opinion on Orphan Drugs|October 23, 2020
Advances in potential treatment options for myeloproliferative neoplasm associated myelofibrosisPrithviraj BoseExpert Review of Hematology|December 11, 2012
Assessing efficacy in myelofibrosis treatment: a focus on JAK inhibitionRami Komrokji, Srdan VerstovsekImmunology and Allergy Clinics of North America|July 16, 2018
Kit Mutations: New Insights and Diagnostic ValueLorenzo Falchi, Srdan VerstovsekClinical Lymphoma, Myeloma & Leukemia|September 1, 2020
A Young Woman with ThrombocytosisPrithviraj BoseImmunology and Allergy Clinics of North America|July 27, 2015
Eosinophilia in Hematologic DisordersLorenzo Falchi, Srdan VerstovsekCell Reports. Medicine|September 27, 2023
Clinical development and management of adverse events associated with FGFR inhibitorsVivek Subbiah, Srdan VerstovsekPageof 69